查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1467832

2024-2032 年黃斑部病變治療市場報告（按類型、疾病階段、給藥途徑、最終用戶和地區）

Macular Degeneration Treatment Market Report by Type, Stage of Disease, Route of Administration, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年全球黃斑部病變治療市場規模達94億美元。

黃斑部病變是一種神經退化性眼部疾病，會影響眼睛並導致視野中心視力模糊或喪失。其特點是視野盲點、視覺扭曲、在低光源條件下看不清楚東西。一些常用的黃斑部病變治療技術包括抗血管新生藥物、光動力雷射療法、隱形眼鏡和過渡鏡片。雷射治療是將專門的隱形眼鏡插入眼睛受影響的區域，並用雷射將其與血管一起密封。抗血管新生藥物用於防止血管阻塞和滲漏。及時治療黃斑部病變有助於增強視力並最大程度地降低慢性失明的風險。

黃斑部病變治療市場趨勢：

大眾中老年黃斑部病變和肥胖發病率的增加是推動市場成長的關鍵因素之一。飲食模式的變化和久坐生活方式的日益普及正在導致黃斑部病變的發展。此外，智慧型手機、筆記型電腦和電視的使用日益增加，導致長時間和過多的螢幕時間也影響了這種疾病的發生。此外，視網膜基因療法的發展，包括將腺相關病毒（AAV）注射到體內以預防異常血管的發育，也為市場成長提供了推動力。與此一致的是，醫療保健基礎設施的顯著改善正在對市場成長產生積極影響。其他因素，包括開發創新有效藥物的廣泛研發（R＆D）活動，以及政府為促進公共衛生而實施的各種舉措，預計將推動市場成長。

本報告回答的關鍵問題

  • 2023年全球黃斑部病變治療市場規模有多大？
  • 2024-2032年全球黃斑部病變治療市場的預期成長率是多少？
  • 推動全球黃斑部病變治療市場的關鍵因素是什麼？
  • COVID-19 對全球黃斑部病變治療市場有何影響？
  • 全球黃斑部病變治療市場按類型分類是怎樣的？
  • 根據疾病階段，全球黃斑部病變治療市場的詳細情形如何？
  • 根據給藥途徑，全球黃斑部病變治療市場的詳細情形如何？
  • 基於最終用戶的全球黃斑部病變治療市場的詳細情形如何？
  • 全球黃斑部病變治療市場的重點區域有哪些？
  • 全球黃斑部病變治療市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球黃斑部病變治療市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按類型

  • 乾性老年黃斑部病變
    • 市場走向
    • 市場預測
  • 濕性老年黃斑部病變
    • 市場走向
    • 市場預測

第 7 章：市場區隔：依疾病階段

  • 早期
    • 市場走向
    • 市場預測
  • 中級階段
    • 市場走向
    • 市場預測
  • 後期
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依管理途徑

  • 靜脈途徑
    • 市場走向
    • 市場預測
  • 玻璃體內途徑
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按最終用戶

  • 醫院
    • 市場走向
    • 市場預測
  • 門診手術中心
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 10 章：市場區隔：按地區

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Aerie Pharmaceuticals Inc.
    • Bausch Health Companies Inc.
    • Bayer AG
    • F. Hoffmann-La Roche Ltd
    • Iveric Bio Inc.
    • Novartis AG
    • Panoptica
    • Pfizer Inc.
    • Phio Pharmaceuticals
    • Regeneron Pharmaceuticals Inc.
    • Regenxbio Inc.
    • Santen Pharmaceutical Co. Ltd.
Product Code: SR112024A5118

The global macular degeneration treatment market size reached US$ 9.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 15.4 Billion by 2032, exhibiting a growth rate (CAGR) of 5.5% during 2024-2032.

Macular degeneration is a neurodegenerative ocular disorder that affects the eyes and causes blurred or loss of vision in the center of the visual field. It is characterized by blind spots in the field of vision, visual distortions and inability to see in low light conditions. Some of the commonly used therapeutic techniques for macular degeneration includes anti-angiogenic drugs, photodynamic laser therapies, contact lenses and transitional lenses. Laser therapy involves the insertion of specialized contact lenses into the affected are of the eye, which are sealed by lasers along with the blood vessels. Anti-angiogenic drugs are used for preventing blockages and leakages in the blood vessels. Timely treatment of macular degeneration treatment can aid in enhancing vision and minimizing the risks of developing chronic blindness.

Macular Degeneration Treatment Market Trends:

The increasing incidences of age-related macular degeneration and obesity among the masses is one of the key factors driving the market growth. The changing dietary patterns and the rising adoption of sedentary lifestyles is leading to the development of macular degeneration. Additionally, the increasing utilization of smartphones, laptops and television, which is leading to prolonged and excessive screen time is also impacting the occurrence of the disorder. Moreover, the development of retinal gene therapies that involves the injection of adeno-associated virus (AAV) into the body for preventing the development of abnormal blood vessels is providing a thrust to the market growth. In line with this, significant improvements in the healthcare infrastructure is positively impacting the market growth. Other factors, including extensive research and development (R&D) activities for the development of innovative and effective drugs, along with the implementation of various government initiatives for promoting public health, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global macular degeneration treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, stage of disease, route of administration and end user.

Breakup by Type:

Dry Age-related Macular Degeneration

Wet Age-related Macular Degeneration

Breakup by Stage of Disease:

Early Stage

Intermediate Stage

Late Stage

Breakup by Route of Administration:

Intravenous Route

Intravitreal Route

Breakup by End User:

Hospitals

Ambulatory Surgical Center

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Aerie Pharmaceuticals Inc., Bausch Health Companies Inc., Bayer AG, F. Hoffmann-La Roche Ltd, Iveric Bio Inc., Novartis AG, Panoptica, Pfizer Inc., Phio Pharmaceuticals, Regeneron Pharmaceuticals Inc., Regenxbio Inc. and Santen Pharmaceutical Co. Ltd.

Key Questions Answered in This Report

  • 1. What was the size of the global macular degeneration treatment market in 2023?
  • 2. What is the expected growth rate of the global macular degeneration treatment market during 2024-2032?
  • 3. What are the key factors driving the global macular degeneration treatment market?
  • 4. What has been the impact of COVID-19 on the global macular degeneration treatment market?
  • 5. What is the breakup of the global macular degeneration treatment market based on the type?
  • 6. What is the breakup of the global macular degeneration treatment market based on the stage of disease?
  • 7. What is the breakup of the global macular degeneration treatment market based on the route of administration?
  • 8. What is the breakup of the global macular degeneration treatment market based on the end user?
  • 9. What are the key regions in the global macular degeneration treatment market?
  • 10. Who are the key players/companies in the global macular degeneration treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Macular Degeneration Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Dry Age-related Macular Degeneration
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Wet Age-related Macular Degeneration
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Stage of Disease

  • 7.1 Early Stage
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Intermediate Stage
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Late Stage
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Intravenous Route
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Intravitreal Route
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Ambulatory Surgical Center
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Aerie Pharmaceuticals Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
    • 15.3.2 Bausch Health Companies Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bayer AG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 F. Hoffmann-La Roche Ltd
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Iveric Bio Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 Novartis AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Panoptica
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Pfizer Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Phio Pharmaceuticals
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 Regeneron Pharmaceuticals Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Regenxbio Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Santen Pharmaceutical Co. Ltd.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Macular Degeneration Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Macular Degeneration Treatment Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Macular Degeneration Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Macular Degeneration Treatment Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Macular Degeneration Treatment Market: Breakup by Stage of Disease (in %), 2023
  • Figure 6: Global: Macular Degeneration Treatment Market: Breakup by Route of Administration (in %), 2023
  • Figure 7: Global: Macular Degeneration Treatment Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Macular Degeneration Treatment Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Macular Degeneration Treatment (Dry Age-related Macular Degeneration) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Macular Degeneration Treatment (Dry Age-related Macular Degeneration) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Macular Degeneration Treatment (Wet Age-related Macular Degeneration) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Macular Degeneration Treatment (Wet Age-related Macular Degeneration) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Macular Degeneration Treatment (Early Stage) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Macular Degeneration Treatment (Early Stage) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Macular Degeneration Treatment (Intermediate Stage) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Macular Degeneration Treatment (Intermediate Stage) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Macular Degeneration Treatment (Late Stage) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Macular Degeneration Treatment (Late Stage) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Macular Degeneration Treatment (Intravenous Route) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Macular Degeneration Treatment (Intravenous Route) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Macular Degeneration Treatment (Intravitreal Route) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Macular Degeneration Treatment (Intravitreal Route) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Macular Degeneration Treatment (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Macular Degeneration Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Macular Degeneration Treatment (Ambulatory Surgical Center) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Macular Degeneration Treatment (Ambulatory Surgical Center) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Macular Degeneration Treatment (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Macular Degeneration Treatment (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: North America: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: North America: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: United States: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: United States: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Canada: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Canada: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Asia-Pacific: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Asia-Pacific: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: China: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: China: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Japan: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Japan: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: India: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: India: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: South Korea: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: South Korea: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Australia: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Australia: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Indonesia: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Indonesia: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Others: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Others: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Europe: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Europe: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Germany: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Germany: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: France: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: France: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: United Kingdom: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: United Kingdom: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Italy: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Italy: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Spain: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Spain: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Russia: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Russia: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Others: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Others: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Latin America: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Latin America: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Brazil: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Brazil: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Mexico: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Mexico: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Middle East and Africa: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Middle East and Africa: Macular Degeneration Treatment Market: Breakup by Country (in %), 2023
  • Figure 77: Middle East and Africa: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Global: Macular Degeneration Treatment Industry: SWOT Analysis
  • Figure 79: Global: Macular Degeneration Treatment Industry: Value Chain Analysis
  • Figure 80: Global: Macular Degeneration Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Macular Degeneration Treatment Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Macular Degeneration Treatment Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Macular Degeneration Treatment Market Forecast: Breakup by Stage of Disease (in Million US$), 2024-2032
  • Table 4: Global: Macular Degeneration Treatment Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 5: Global: Macular Degeneration Treatment Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Macular Degeneration Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Macular Degeneration Treatment Market: Competitive Structure
  • Table 8: Global: Macular Degeneration Treatment Market: Key Players